Base Year
Historical Year
Forecast Year
The global erythropoietin drugs market was valued at USD 10.89 billion in 2023, driven by the increasing prevalence of chronic kidney diseases and diabetes, cancer across the globe. The market size is anticipated to grow at a CAGR of 5.7% during the forecast period of 2024-2032 to achieve a value of USD 17.93 billion by 2032.
Erythropoietin is a hormone solely produced by the kidneys in a human body. This hormone helps in generating enough erythrocytes (red blood cells) in body by delivering proper amount of oxygen among body tissues. When this oxygen turns into energy, carbon dioxide releases. Red blood cells are also responsible for delivering carbon dioxide to the lung to exhale it out of the body. Usually, when low oxygen levels are encountered, the specialized cells located in the kidneys boosts the production of Erythropoietin.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
These drugs are widely used for the treatment of anemia, kidney diseases, cancer, and patients undergoing chemotherapies or dialysis. These drugs can be consumed in the form of injections or subcutaneous implants. Stimulation of bone marrow helps erythropoietin drugs to produce more red blood cells, resulting in improved capacity of carrying oxygen, and relieve the symptoms related with anemia.
There are several key trends running in the market and some of them include the rising prevalence of chronic kidney diseases. The rise in ageing population is causing increased prevalence of diabetes and hypertension, leading to higher demand for erythropoietin drugs. Along with it, the increasing use of these drugs in oncology, advancements in drug delivery systems, expiration of biosimilars and patents are also among the key trends aiding the market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Drug Type
Market Breakup by Product Type
Market Breakup by Application
The global market size for erythropoietin drugs has been constantly growing and is expected to witness gradual growth in future as well. The increasing prevalence of anaemia and increasing demand for biosimilar and biological drugs are directly contributing to the growth of market size. The major cause of anaemia such as unhealthy diets and increasing chronic diseases, along with intestinal issues, and some other infections are increasing the demand for biosimilar drugs, and directly contributing to the growth of the erythropoietin drugs market size.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Due to the increasing rate of development of anaemia in more people the demand for erythropoietin drugs has also increased as they are approved by healthcare professionals easily and the research authorities. These fast approvals result in increased availability and increased production of the drug to directly support the growth of the erythropoietin drug market size.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Type |
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global market was valued at USD 10.89 billion in 2023.
The global erythropoietin market size is anticipated to grow at a CAGR of 5.7% during the forecast period of 2024-2032 and reach a market value of USD 17.93 billion by 2032.
The rising incidence and prevalence of chronic kidney disease and cancer worldwide are the major drivers for the global erythropoietin market.
The different types of drugs in the market are biologics and biosimilars.
The different type of products in the market includes epoetin-alfa, epoetin-beta, and darbepoetin-alfa, among others.
The end users of the erythropoietin drugs include hospitals, homecare, and speciality clinics, among others.
The different applications of erythropoietin drugs include haematology, kidney disorder, cancer, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The key players involved in the market are Amgen Inc., Biocon Limited, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Intas Pharmaceuticals Ltd., Johnson & Johnson, LG Chem Ltd., Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Sun Pharmaceutical Industries Limited.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share